CH642347A5 - Die mit cyclodextrin gebildeten einschlusskomplexe des allycins sowie verfahren zur herstellung dieser komplexe und diese enthaltende arzneimittelpraeparate. - Google Patents

Die mit cyclodextrin gebildeten einschlusskomplexe des allycins sowie verfahren zur herstellung dieser komplexe und diese enthaltende arzneimittelpraeparate. Download PDF

Info

Publication number
CH642347A5
CH642347A5 CH1097979A CH1097979A CH642347A5 CH 642347 A5 CH642347 A5 CH 642347A5 CH 1097979 A CH1097979 A CH 1097979A CH 1097979 A CH1097979 A CH 1097979A CH 642347 A5 CH642347 A5 CH 642347A5
Authority
CH
Switzerland
Prior art keywords
cyclodextrin
allycin
ccm
complexes
allycine
Prior art date
Application number
CH1097979A
Other languages
German (de)
English (en)
Inventor
Jozsef Szejtli
Lajos Szente
Gabor Kulcsar
Gyoergy Koermoeczy
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of CH642347A5 publication Critical patent/CH642347A5/de

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CH1097979A 1978-12-12 1979-12-11 Die mit cyclodextrin gebildeten einschlusskomplexe des allycins sowie verfahren zur herstellung dieser komplexe und diese enthaltende arzneimittelpraeparate. CH642347A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU78CI1871A HU177081B (en) 1978-12-12 1978-12-12 Process for preparing the occlusion complex of allicin with cyclodextrin

Publications (1)

Publication Number Publication Date
CH642347A5 true CH642347A5 (de) 1984-04-13

Family

ID=10994715

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1097979A CH642347A5 (de) 1978-12-12 1979-12-11 Die mit cyclodextrin gebildeten einschlusskomplexe des allycins sowie verfahren zur herstellung dieser komplexe und diese enthaltende arzneimittelpraeparate.

Country Status (11)

Country Link
JP (1) JPS55115866A (ja)
AT (1) AT363492B (ja)
CH (1) CH642347A5 (ja)
DE (1) DE2948869A1 (ja)
DK (1) DK526779A (ja)
FR (1) FR2444060A1 (ja)
GB (1) GB2061987B (ja)
HU (1) HU177081B (ja)
NO (1) NO794044L (ja)
SU (1) SU938732A3 (ja)
YU (1) YU299079A (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU184066B (en) 1979-12-28 1984-06-28 Chinoin Gyogyszer Es Vegyeszet Plant growth regulating substance and process for preparing such compound
JPS5920230A (ja) * 1982-07-19 1984-02-01 チバ−ガイギ−・アクチエンゲゼルシヤフト ピルプロフエン含有薬剤
FR2550193A1 (fr) * 1983-08-05 1985-02-08 Sal Fine Chemicals Internation Complexes d'inclusion de trisulfure de methyle et d'allyle avec des cyclodextrines, leur procede de preparation et compositions pharmaceutiques les contenant
HU196230B (en) * 1983-12-29 1988-10-28 Chinoin Gyogyszer Es Vegyeszet Process for producing water-soluble forms of polyene antibiotics and pharmaceutics comprising such active ingredient and plant protective with antifungal effect
DE3678356D1 (de) * 1985-08-06 1991-05-02 Kao Corp Fluessige shampoozusammensetzung.
DE3638290A1 (de) * 1986-11-07 1988-05-19 Herbe Wirkstoffe Gmbh Arzneimittelzubereitung
US4774329A (en) * 1987-08-04 1988-09-27 American Maize-Products Company Controlled release agent for cetylpyridinium chloride
DK0392608T3 (da) * 1989-04-12 1995-11-20 Procter & Gamble Faste konsumentproduktsammensætninger, der indeholder cyclodextrinkomplekser af lille partikelstørrelse
SE8902235D0 (sv) * 1989-06-20 1989-06-20 Haessle Ab Novel cyclodextrin inclusion complexes
CA2013485C (en) * 1990-03-06 1997-04-22 John Michael Gardlik Solid consumer product compositions containing small particle cyclodextrin complexes
DE4024155C2 (de) * 1990-07-30 1995-12-07 Marcela Dipl Ing Holzhey Verwendung eines "Allicin-Urotropin" Produktes für den Bereich der inneren Behandlung (oral, Injektionen und Dauertropfinfusionen) von Menschen und Tieren bei Pilzerkrankungen
DE4338508A1 (de) * 1993-11-11 1995-05-18 Asta Medica Ag Arzneimittelzubereitungen enthaltend Thioctsäure oder Dihydroliponsäure in Form von Einschlußverbindungen mit Cyclodextrinen oder Cyclodextrinderivaten und in Form von Granulaten, Kau- oder Brausetabletten
DE19500863A1 (de) * 1995-01-13 1996-07-18 Consortium Elektrochem Ind Verfahren zur Herstellung von Ajoen
GB0120887D0 (en) * 2001-08-29 2001-10-17 Sahajanand Biotech Private Ltd Local drug delivery system in coronary stents
GB0122793D0 (en) * 2001-09-21 2001-11-14 Stone Island Holdings Ltd Allicin
WO2005089571A1 (es) * 2004-03-03 2005-09-29 Mousala, S., L. Utilización de extractos y compuestos de plantas del género allium como conservantes en las industrias alimentaria y agroalimentaria
GB0422582D0 (en) * 2004-10-11 2004-11-10 Nasaleze Patents Ltd Pharmaceutical compositions
CN107802842B (zh) * 2016-09-07 2022-04-12 汤臣倍健股份有限公司 大蒜素矫味制剂及其制备方法
CN107789345B (zh) * 2016-09-07 2022-06-28 汤臣倍健股份有限公司 矫味大蒜素-环糊精复合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3061444A (en) * 1960-10-07 1962-10-30 Gen Foods Corp Inclusion compounds incorporating edible juice constituents
HU174699B (hu) * 1977-07-01 1980-03-28 Chinoin Gyogyszer Es Vegyeszet Sposob poluchenija natural'nykh i sinteticheskikh ciklodektrinnykh okkluzionnykh kompleksov prjaznostej, aromatov i vkusnykh vehhestv

Also Published As

Publication number Publication date
SU938732A3 (ru) 1982-06-23
AT363492B (de) 1981-08-10
HU177081B (en) 1981-07-28
ATA782979A (de) 1981-01-15
JPS55115866A (en) 1980-09-06
DE2948869A1 (de) 1980-07-03
GB2061987A (en) 1981-05-20
DE2948869C2 (ja) 1992-07-09
DK526779A (da) 1980-06-13
YU299079A (en) 1983-06-30
NO794044L (no) 1980-06-13
FR2444060A1 (fr) 1980-07-11
GB2061987B (en) 1983-05-18
JPS642105B2 (ja) 1989-01-13
FR2444060B1 (ja) 1984-06-29

Similar Documents

Publication Publication Date Title
CH642347A5 (de) Die mit cyclodextrin gebildeten einschlusskomplexe des allycins sowie verfahren zur herstellung dieser komplexe und diese enthaltende arzneimittelpraeparate.
CH630069A5 (de) Verfahren zur herstellung von neuen cystein-derivaten.
DD246245A5 (de) Herbizide zusammensetzung
DE2913211A1 (de) 2-(2-thenoylthio)propionylglycin, verfahren zu seiner herstellung und es enthaltende pharmazeutische mittel
DE2433407A1 (de) Sulfate von hydroxyaethylstaerke
EP0721940A1 (de) Verfahren zur Herstellung von Ajoen
DE2406628C2 (de) Alkylester von Partricin, Verfahren zu ihrer Herstellung und diese Ester enthaltende pharmazeutische Mittel
CH635344A5 (en) Process for the preparation of d,l-5-methyltetrahydrofolic acid and its salts
DE2905373C2 (de) Chlorjodide quaternärer Ammoniumverbindungen und diese enthaltende pharmazeutische Präparate
DE69322721T2 (de) Sulfonierte Verbindungen aus Beta-Cyclodextrinpolymer und diese enthaltendes Medikament welches die Hyperplasie von Gefässwanden hemmt
DE1906699A1 (de) Neue Polymyxinderivate und Verfahren zu deren Herstellung
DE69024193T2 (de) Ascorbinsäure-derivate
DE2514533A1 (de) Polysaccharidkomplexe und verfahren zu deren herstellung
DE69328357T2 (de) Komplex von 2-aminoäthansulfonsäure und zink
EP0183194B1 (de) Menadioncholinbisulfit-Addukt und Verfahren zu dessen Herstellung
DE1938052C3 (de) Antibiotische Siomycin A-Derivate und ihre Herstellung
DE69317539T2 (de) Herbizid, das ein zyklisches hexapeptid als aktiven inhaltsstoff enthält
EP0046565B1 (de) Neues Sparteinderivat, Verfahren zu seiner Herstellung, das Derivat enthaltende Arzneimittel und Verfahren zur Herstellung der Arzneimittel
US2963401A (en) Rimocidin and methods for its recovery
CH676360A5 (en) Purificn. of antiviral gossypol cpd. - by recrystallisation from ether with hexane
DE2645528C3 (de) Antibiotisch wirksame Pyrrole [2,1c] -1,4benzdiazepine
DE1129148B (de) Verfahren zur Herstellung von Heparin-Derivaten zytostatisch wirkender Stoffe
CH639271A5 (de) Therapeutisches praeparat und verfahren zu dessen herstellung.
DE2949594C2 (de) Kanamycintannat, Verfahren zu seiner Hersellung und pharmazeutische Mittel
DE3204446A1 (de) Dihydroxyanthrone, sowie pharmazeutische und kosmetische mittel, die diese verbindungen enthalten

Legal Events

Date Code Title Description
PL Patent ceased